title: Clostridium difficile: an update.
abstract: Clostridium difficile causes a spectrum of diarrheal illness with the potential for major medical consequences. Although most cases respond quickly to treatment, C. difficile colitis may be severe and life threatening. Recurrent disease represents a particularly challenging problem.
authors.affiliation: Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN, USA.
authors.forename: Jonathan
authors.initials: J
authors.lastname: Gonenne
authors.forename: Darrell S
authors.initials: DS
authors.lastname: Pardi
mesh_terms: D000837:Anion Exchange Resins / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use; D016360:Clostridioides difficile; D004761:Enterocolitis, Pseudomembranous / Q000175:diagnosis* / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy; D008795:Metronidazole / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use; D055502:Secondary Prevention; D014481:United States / Q000453:epidemiology; D014640:Vancomycin / Q000627:therapeutic use
chemical_list: D000837:Anion Exchange Resins; D000890:Anti-Infective Agents; D008795:Metronidazole; D014640:Vancomycin; D012293:Rifampin